Novel presentation of Plasmodium vivax malaria with acute kidney injury and hemolytic uremic syndrome

Conclusion Clinical association of vivax malaria with TMA leading to HUS is novel and suggests parasite related severe endothelial injury. Future studies are needed to demonstrate interaction of parasite with endothelium and factors related to it.
Source: Pediatric Infectious Disease - Category: Pediatrics Source Type: research

Related Links:

Source: BMJ Comments - Category: General Medicine Source Type: forums
The World Health Organization has suspended testing the malaria drug hydroxychloroquine in COVID-19 patients due to safety concerns, WHO Director General Tedros Adhanom Ghebreyesus said on Monday.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
Cordero, a 41-year-old Tony nominee, was initially hospitalized March 30 after developing pneumonia and later tested positive for the coronavirus.
Source: Health News: CBSNews.com - Category: Consumer Health News Source Type: news
This study, for instance, attributes a patient’s waitlist/transplant outcome to the very last dialysis facility the patient was associated with.  In epidemiology speak, this means the causal inference authors are trying to draw between for-profit status and good transplant outcomes is subject to time-varying confounding. As an example, if one is seeking an association between testosterone levels and risk of a heart attack, using the last testosterone level available would be a poor way of doing this study because testosterone levels are known to vary over time. The same applies to dialysis facilities. Patie...
Source: The Health Care Blog - Category: Consumer Health News Authors: Tags: Medical Practice Physicians Eric Weinhandl JAMA medical research public health Public Policy public policy research Source Type: blogs
Publication date: Available online 24 May 2020Source: Journal of Pharmaceutical and Biomedical AnalysisAuthor(s): Po-Yeh Lin, Shih-Ming Chen, Chin-Ling Hsieh, Chia-Yu Lin, Yu-Sheng Huang, Kenji Hamase, Jen-Ai Lee
Source: Journal of Pharmaceutical and Biomedical Analysis - Category: Drugs & Pharmacology Source Type: research
Source: European Journal of Nuclear Medicine and Molecular Imaging - Category: Nuclear Medicine Source Type: research
Condition:   Corona Virus Infection Intervention:   Drug: Baricitinib Sponsor:   IRCCS Policlinico S. Matteo Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conditions:   COVID;   Pneumonia, Viral Intervention:   Device: Bedside lung ultrasound Sponsor:   Kanuni Sultan Suleyman Training and Research Hospital Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conditions:   Sickle Cell Disease;   Sickle Cell Anemia Intervention:   Drug: Voxelotor Sponsor:   Global Blood Therapeutics Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conditions:   COVID 19;   SARS-CoV 2;   Pneumonia Interventions:   Drug: Mavrilimumab;   Drug: Placebos Sponsors:   The Cleveland Clinic;   Kiniksa Pharmaceuticals, Ltd. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Anemia | Dialysis | Epidemiology | Health | Hemodialysis | Hemolytic Uremic Syndrome (HUS) | Infectious Diseases | International Medicine & Public Health | Malaria | Nephritis | Papanicolaou (Pap) Smear | Parasitic Diseases | Parasitology | Pediatrics | Peritoneal Dialysis | Pneumonia | Renal Failure | Study | Thrombocytopenia | Urology & Nephrology